News

Pumas-AI looks to democratize access to drug development tools
September 07, 2021 | Press Release

The University of Maryland, Baltimore startup recently completed a big upgrade for its 2.0 version. Here's why the cofounders say it matters for science, and healthcare. For the cofounders of University of Maryland, Baltimore startup Pumas-AI, technology has the power to democratize access to advanced tools. The startup’s pharmaceutical modeling and simulation platform has two products...

UMB Startup Pumas-AI Receives Exclusive License
August 18, 2021 | Press Release

Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to enhancements to Pumas, an end-to-end pharmaceutical modeling and simulation platform for quantitative analysis across the drug development lifecycle. Pumas 2.0 builds on the company’s existing platform, which also employs technology licensed from UMB...

Collaborative work by Pumas-AI and Otsuka to be presented at NKF '21
February 18, 2021 | Blog

We are excited to announce that the collaborative work performed by Otsuka Pharmaceutical Development & Commercialization and Pumas-AI scientists will be presented at National Kidney Foundation 2021 on April 6-10, 2021! The modeling used Pumas software to explore urine osmolality and GFR relationship. Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term...

Congrats to Dr. Rackauckas – awarded 2020 ISoP Emerging Scientist!
November 09, 2020 | Blog

Dr. Christopher Rackauckas, our Director of Scientific Research, was recently awarded for the 2020 ISoP Emerging Scientist Award. The International Society of Pharmacometrics (ISoP) Awards Ceremony was hosted by the Eleventh American Conference of Pharmacometrics (ACoP11) on Monday, November 9, 2020. The Emerging Scientist Award, the highest early career award given by ISoP, was granted to...

UMB-born startup launches pharmaceutical modeling platform Pumas 1.0
August 12, 2020 | Press Release

A startup launched out by faculty at University of Maryland, Baltimore and MIT researchers collaborated to launch Pumas 1.0, a predictive analytics platform that aids in the development cycle of pharmaceutical drugs. What that means is Pumas 1.0 takes the data a drug company has and simulates the success rate or possible outcome of a drug. Creating models and simulations through the algorithm...

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System
May 07, 2020 | Press Release

Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to Lyv, a cutting-edge clinical decision support system designed to help health care professionals personalize treatment trajectories for patients in real-time. The Lyv platform leverages clinical research and Electronic Health Record (EHR) data from millions of patients to derive…

University of Maryland, Baltimore Researchers' Startup, Pumas-AI, Launches Cutting-Edge Healthcare Software
August 08, 2019 | Feature

Pumas-AI, a new University of Maryland, Baltimore (UMB) startup company established by University of Maryland School of Pharmacy (SOP) faculty members Vijay Ivaturi, PhD, assistant professor, and Joga Gobburu, PhD, MBA, professor, has released its first, cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical Modeling and Simulation (Pumas), the s...

Pumas-AI Launches Julia Language-Based Software to Advance Drug Development, Patient Care
August 04, 2019 | Feature

Pumas-AI – a new company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor in the Department of Pharmacy Practice and Science (PPS), and Joga Gobburu, PhD, MBA, professor in PPS – is proud to announce the release of its first cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical...

Researchers establish Pumas-AI, launch Pumas pharmaceutical software
July 22, 2019 | FEATURE

Pumas-AI, a new company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor in the Department of Pharmacy Practice and Science, and Joga Gobburu, PhD, MBA, professor in the department, is proud to announce the release of its first, cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical...

The Future of Modelling and Simulations in Pharmacometrics with Julia
July 19, 2019 | blog

Pharmacometricians have been early adopters of mathematical programming tools. We use tools that allow us to solve real problems. However, given the diversity of problems that we solve, our field has seen a split in the languages that we use due to the problems they are tailored to solve. R has become a staple in the community due to its strong statistics, data manipulation and plotting libra...

The story of Pumas
July 19, 2019 | blog

At the outset, I would like to acknowledge and thank all those who contributed to development of Pumas. Here is a complete list in no particular order: Chris Rackauckas; Simon Byrne; Andreas Noack; Patrick Mogensen; José Bayoán Santiago Calderón; Yingbo Ma; Vaibhav Dixit; Xingjian Guo; Shubham Maddhashiya; Harrison Gordin; David Widmann; Joakim Nyberg; Joga Gobburu. I would also like to ac...